Enveric Biosciences Inc vs Lemonade Inc — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Lemonade Inc trades at $67.33 (market cap $5.07B). The key difference: Lemonade Inc is far larger — about 953× Enveric Biosciences Inc's market cap, and Lemonade Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | LMND | |
|---|---|---|
Market Cap | $5.32M | $5.07B |
Sector | Health | Financials |
52-Week High | $17.40 | $96.57 |
52-Week Low | $1.28 | $36.28 |
Enterprise Value | $408.82K | $4.90B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LMND trades at $70.14, down 0.68% on the day, with a bullish technical signal supported by moving averages. The company shows accelerating revenue growth, reaching $737.9M in 2025, while narrowing net losses. Recent expansion into new states and a renegotiated reinsurance program highlight operational momentum, though profitability remains negative.
The outlook balances growth potential against persistent losses. Investment appeal hinges on continued premium expansion and path to profitability, but risks include high valuation multiples and competitive pressures. Analyst sentiment is mixed, with a $69.60 consensus target slightly below the current price.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →